Detailed answers about NEUROCENTRX PHARMA LIMITED, including incorporation, status, business activity, and accounts information.
When was NEUROCENTRX PHARMA LIMITED founded?
NEUROCENTRX PHARMA LIMITED was officially incorporated on 18 July 2013 and is registered under company number SC454814. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEUROCENTRX PHARMA LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NEUROCENTRX PHARMA LIMITED?
NEUROCENTRX PHARMA LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NEUROCENTRX PHARMA LIMITED do?
NEUROCENTRX PHARMA LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is NEUROCENTRX PHARMA LIMITED's registered address?
The registered office address of NEUROCENTRX PHARMA LIMITED is LEVEL 5,, 9 HAYMARKET SQUARE, EDINBURGH, SCOTLAND, EH3 8RY. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEUROCENTRX PHARMA LIMITED financially stable?
The most recent accounts for NEUROCENTRX PHARMA LIMITED were made up to 31 October 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 September 2026.
Does NEUROCENTRX PHARMA LIMITED have any charges or mortgages?
NEUROCENTRX PHARMA LIMITED has 1 registered charge, of which 1 is outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.